Preparing the article…
If a translation is needed, this may take a few seconds.
If a translation is needed, this may take a few seconds.
The African Union has obtained 270 million doses of anti-Covid vaccines to be distributed among countries on the continent. 50 million doses will be available between April and June. They are purchased by the AU from Pfizer, AstraZeneca and Johnson&Johnson laboratories. These orders are not the only sources of supply for Africa, which also benefits from the Covax initiative launched by the WHO, and from measures taken at the state level…

It is a strong signal that the African Union is sending: the continent is not waiting for global charity to obtain its anti-Covid vaccine doses. And intends to supply itself just like the rest of the planet from the major laboratories. 270 million vaccines will be purchased from Pfizer and AstraZeneca, in particular.
But Africa is not giving up on the Covax initiative, launched jointly by the World Health Organization and wealthy countries, in order to promote equitable access to all countries of vaccines developed in the world. Only the African Union fears that the volumes available between February and June through Covax will barely be sufficient to vaccinate healthcare workers.
Yet currently, the continent is being hit by a second wave far deadlier than the first, and must move faster. These two channels for accessing vaccines are not the only ones; some countries do not hesitate to order directly.
Thus, Algeria has purchased the Russian Sputnik V vaccine. Morocco, for its part, opts for AstraZeneca's product and especially that of the Chinese Sinopharm, part of which will be produced in a Moroccan factory. Senegal, finally, has just announced that it is also in discussions with Sinopharm for the first phase of its vaccination program.
► Also read: Covid-19: what access to a future vaccine for Africa?
Our editors' picks of what matters. Monday to Friday.
By subscribing, you accept our privacy policy.